Beverly Meadows

765 total citations
13 papers, 610 citations indexed

About

Beverly Meadows is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Beverly Meadows has authored 13 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 4 papers in Pediatrics, Perinatology and Child Health and 3 papers in Pharmacology. Recurrent topics in Beverly Meadows's work include Drug Transport and Resistance Mechanisms (10 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Beverly Meadows is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Beverly Meadows collaborates with scholars based in United States, Israel and Italy. Beverly Meadows's co-authors include Susan E. Bates, Tito Fojo, Robert W. Robey, Susan Bakke, Barry R. Goldspiel, Tom Smith, Maria Merino, Seth M. Steinberg, William D. Figg and Joanna Regis and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Beverly Meadows

13 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beverly Meadows United States 11 382 170 164 146 82 13 610
Sachin Shah United States 13 286 0.7× 52 0.3× 211 1.3× 54 0.4× 57 0.7× 25 737
Christian Trautwein Germany 16 141 0.4× 41 0.2× 204 1.2× 62 0.4× 78 1.0× 31 800
E. Boven Netherlands 11 503 1.3× 46 0.3× 308 1.9× 66 0.5× 63 0.8× 25 770
Mahdi Aghili Iran 15 327 0.9× 27 0.2× 105 0.6× 151 1.0× 111 1.4× 68 745
E Warner Canada 4 527 1.4× 95 0.6× 88 0.5× 103 0.7× 61 0.7× 7 807
Patrick J. Medina United States 14 210 0.5× 42 0.2× 163 1.0× 70 0.5× 52 0.6× 22 719
Kyung Eob Choi United States 15 377 1.0× 49 0.3× 182 1.1× 89 0.6× 38 0.5× 26 775
Femke M. de Man Netherlands 10 245 0.6× 48 0.3× 219 1.3× 77 0.5× 40 0.5× 19 539
Mark J. Ratain United States 12 351 0.9× 44 0.3× 153 0.9× 60 0.4× 58 0.7× 21 602
Hiroo Ishida Japan 19 544 1.4× 76 0.4× 278 1.7× 73 0.5× 102 1.2× 70 877

Countries citing papers authored by Beverly Meadows

Since Specialization
Citations

This map shows the geographic impact of Beverly Meadows's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly Meadows with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly Meadows more than expected).

Fields of papers citing papers by Beverly Meadows

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverly Meadows. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly Meadows. The network helps show where Beverly Meadows may publish in the future.

Co-authorship network of co-authors of Beverly Meadows

This figure shows the co-authorship network connecting the top 25 collaborators of Beverly Meadows. A scholar is included among the top collaborators of Beverly Meadows based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverly Meadows. Beverly Meadows is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Bates, Susan E., Susan Bakke, Min H. Kang, et al.. (2004). A Phase I/II Study of Infusional Vinblastine with the P-Glycoprotein Antagonist Valspodar (PSC 833) in Renal Cell Carcinoma. Clinical Cancer Research. 10(14). 4724–4733. 56 indexed citations
2.
Abraham, Jame, Susan Bakke, Ann Rutt, et al.. (2002). A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma. Cancer. 94(9). 2333–2343. 82 indexed citations
3.
Köhler, David, Michael Montello, Barry R. Goldspiel, et al.. (2002). ASHP Guidelines on Preventing Medication Errors with Antineoplastic Agents. American Journal of Health-System Pharmacy. 59(17). 1648–1668. 96 indexed citations
4.
Bates, Susan E., Min H. Kang, Beverly Meadows, et al.. (2001). A Phase I study of infusional vinblastine in combination with the p-glycoprotein antagonist PSC 833 (valspodar). Cancer. 92(6). 1577–1590. 63 indexed citations
5.
Kang, Min H., Raymond C. Bergan, Jame Abraham, et al.. (2001). Phase I Study of Infusional Paclitaxel in Combination With the P-Glycoprotein Antagonist PSC 833. Journal of Clinical Oncology. 19(3). 832–842. 65 indexed citations
6.
Robey, Robert W., Susan Bakke, Wilfred D. Stein, et al.. (1999). Efflux of Rhodamine From CD56+ Cells as a Surrogate Marker for Reversal of P-Glycoprotein–Mediated Drug Efflux by PSC 833. Blood. 93(1). 306–314. 57 indexed citations
7.
Robey, Robert W., Susan Bakke, Wilfred D. Stein, et al.. (1999). Efflux of Rhodamine From CD56+ Cells as a Surrogate Marker for Reversal of P-Glycoprotein–Mediated Drug Efflux by PSC 833. Blood. 93(1). 306–314. 6 indexed citations
8.
Lush, Richard M., Beverly Meadows, Antonio Tito Fojo, et al.. (1997). Initial Pharmacokinetics and Bioavailability of PSC 833, a P‐Glycoprotein Antagonist. The Journal of Clinical Pharmacology. 37(2). 123–128. 20 indexed citations
9.
Meadows, Beverly, et al.. (1997). Detection of in vivo P-glycoprotein inhibition by PSC 833 using Tc-99m sestamibi.. PubMed. 3(4). 545–52. 79 indexed citations
10.
Bates, Susan E., Beverly Meadows, Barry R. Goldspiel, et al.. (1995). A pilot study of amiodarone with infusional doxorubicin or vinblastine in refractory breast cancer. Cancer Chemotherapy and Pharmacology. 35(6). 457–463. 21 indexed citations
11.
Goldspiel, Barry R., Andrea Denicoff, Eben Tucker, et al.. (1995). A pilot study of amiodarone with infusional doxorubicin or vinblastine in refractory breast cancer. Cancer Chemotherapy and Pharmacology. 35(6). 457–463. 3 indexed citations
12.
13.
Bates, Susan E., et al.. (1994). Chemoresistance in the clinic: overview 1994.. PubMed. 81 Suppl 2. 55s–61s. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sachin Shah Breakdown of academic impact, for papers by Christian Trautwein Breakdown of academic impact, for papers by E. Boven Breakdown of academic impact, for papers by Mahdi Aghili Breakdown of academic impact, for papers by E Warner Breakdown of academic impact, for papers by Patrick J. Medina Breakdown of academic impact, for papers by Kyung Eob Choi Breakdown of academic impact, for papers by Femke M. de Man Breakdown of academic impact, for papers by Mark J. Ratain Breakdown of academic impact, for papers by Hiroo Ishida
Rankless by CCL
2026